After 'initial shock,' generics supply chain likely to weather COVID-19 blows: analyst

27th March 2020 Uncategorised 0

The specter of global drug shortages looms large amid the coronavirus pandemic. But so far, the supply chain is holding steady and prices are going up—in the generic drug business, at least. One analyst, in fact, figures COVID-19 could turn out to be a profitable time for the generics industry.

More: After 'initial shock,' generics supply chain likely to weather COVID-19 blows: analyst
Source: fierce